Purpose: The aim of this study was to determine the ability of 2-deoxy-2-[(18)F]fluoro-d-glucose positron emission tomography (FDG-PET) to predict the clinical outcome of previously treated patients with Hodgkin's Disease (HD).
Patients And Methods: Thirty-two patients were studied with PET within a median interval of 5.2 months after treatment.
Purpose: The aim of this study was to determine the impact of positron emission tomography (PET) with 2-deoxy-2-[18F]fluoro-D-glucose (FDG) and combined conventional imaging on clinical stage and their ability to predict the clinical outcome of previously treated lymphoma patients.
Procedures: Seventy-eight patients with Non-Hodgkin's Lymphoma (NHL) were studied with PET within a median interval of 5.3 months after treatment.
Unlabelled: Breast density affects the mammographic detectability of breast cancer. The study aimed to evaluate the impact of breast density on the (18)F-FDG uptake of normal breast tissue.
Methods: The study population consisted of 45 women (median age, 54 y; age range, 42-77 y).
Unlabelled: This study was conducted to determine the ability of (18)F-FDG PET and conventional imaging (CI) to predict the outcomes in breast cancer patients who have previously undergone primary treatment.
Methods: The study population consisted of 61 female patients (median age, 54 y; range, 32--91 y) who were reevaluated with (18)F-FDG PET and CI after treatment. The median interval between the last treatment and PET was 0.